ACE-2 plays a major role in PAH and SARS-CoV-2, but it is unclear whether ACE-2 reduction in PAH will promote or suppress SARS-CoV-2-induced lung injury [63]. The gene discussed is ACE2; the disease is pulmonary arterial hypertension.